These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15195189)

  • 21. Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.
    Weiss KD
    Pediatrics; 2004 Jan; 113(1 Pt 1):134. PubMed ID: 14702464
    [No Abstract]   [Full Text] [Related]  

  • 22. My brother has severe sepsis--should he receive Xigris?
    Suter PM
    Minerva Anestesiol; 2007 Dec; 73(12):647-50. PubMed ID: 18046295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human activated protein C for severe sepsis.
    Ott A; Verbrugh HA
    N Engl J Med; 2001 Jul; 345(3):220; author reply 220-1. PubMed ID: 11463023
    [No Abstract]   [Full Text] [Related]  

  • 24. Inflammation and coagulation: implications for the septic patient.
    Dellinger RP
    Clin Infect Dis; 2003 May; 36(10):1259-65. PubMed ID: 12746771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. We've made progress in the treatment of sepsis, so do we still need sepsis trials?
    Vincent JL
    Minerva Anestesiol; 2013 Jan; 79(1):1-2. PubMed ID: 23299044
    [No Abstract]   [Full Text] [Related]  

  • 26. Paving a new road for generating evidence-based care in sepsis*.
    Annane D
    Crit Care Med; 2014 Jul; 42(7):1743-4. PubMed ID: 24933058
    [No Abstract]   [Full Text] [Related]  

  • 27. Drotrecogin alfa (activated) for severe sepsis.
    Maglio D
    Conn Med; 2002 Mar; 66(3):145-50. PubMed ID: 11957766
    [No Abstract]   [Full Text] [Related]  

  • 28. Protein C may be sepsis solution.
    Garber K
    Nat Biotechnol; 2000 Sep; 18(9):917-8. PubMed ID: 10973198
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of activated protein C (drotrecogin alfa) in a patient with sepsis and respiratory failure on ultra high frequency jet ventilation.
    Datta D; McNamee M
    Conn Med; 2003 Jan; 67(1):11-2. PubMed ID: 12630184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human activated protein C for severe sepsis.
    Kapur S; Kupfer Y; Tessler S
    N Engl J Med; 2001 Jul; 345(3):219-20; author reply 220-1. PubMed ID: 11463021
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant human activated protein C for severe sepsis.
    Greisman SE; Johnston CA; Gosnell MS
    N Engl J Med; 2001 Jul; 345(3):219; author reply 220-1. PubMed ID: 11463022
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of heparin and allied compounds in the treatment of sepsis.
    Cornet AD; Smit EG; Beishuizen A; Groeneveld AB
    Thromb Haemost; 2007 Sep; 98(3):579-86. PubMed ID: 17849046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Kalenka A
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698-9; author reply 1699-70. PubMed ID: 15273924
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of severe sepsis with Xigris: implications for the clinical nurse specialist.
    Powers J; Jacobi J
    Clin Nurse Spec; 2003 May; 17(3):128-30. PubMed ID: 12792186
    [No Abstract]   [Full Text] [Related]  

  • 35. Drotrecogin alfa: a role in emergency department treatment of severe sepsis?
    McLeay AM
    Emerg Med Australas; 2004 Aug; 16(4):324-35. PubMed ID: 15283720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meeting unmet needs in patients with sepsis: the role of drotrecogin alfa (activated).
    Morris PE
    Am J Crit Care; 2003 Mar; 12(2):94-7. PubMed ID: 12625165
    [No Abstract]   [Full Text] [Related]  

  • 37. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis].
    Girbes AR; Polderman KH; Beishuizen A; van Zanten AR; Schultz MJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1265-6; author reply 1266. PubMed ID: 16796179
    [No Abstract]   [Full Text] [Related]  

  • 38. Still puzzled by additional data from the PROWESS study.
    Schultz MJ
    Crit Care Med; 2005 Sep; 33(9):2146; author reply 2146-7. PubMed ID: 16148509
    [No Abstract]   [Full Text] [Related]  

  • 39. [Protein C--a new opening in the treatment of sepsis syndrome].
    Petäjä J; Heikinheimo M
    Duodecim; 2002; 118(12):1217-9. PubMed ID: 12239812
    [No Abstract]   [Full Text] [Related]  

  • 40. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.